Literature DB >> 2169206

Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.

J L Wallace1, C M Keenan, D N Granger.   

Abstract

The hypothesis that neutrophils play an important role in the pathogenesis of gastric ulceration induced by nonsteroidal anti-inflammatory drugs (NSAIDs) was tested in rats. Rats made neutropenic by prior treatment with an antibody to rat neutrophils raised in goat were found to be significantly more resistant to the gastric-damaging actions of indomethacin or naproxen than were control rats or rats pretreated with normal goat serum. The reduction of damage in neutropenic rats was not due to effects of the antineutrophil serum on either gastric acid secretion or the ability of indomethacin or naproxen to inhibit prostaglandin synthesis. Gastric cyclooxygenase activity was inhibited by greater than 95% in both normal and neutropenic rats that received indomethacin or naproxen. Reduction of circulating neutrophil numbers by treating rats with methotrexate also resulted in a significant reduction in the susceptibility to gastric damage induced by indomethacin. Since activation of circulating neutrophils appeared to be important in the development of gastric erosions after administration of indomethacin, and in the significant changes in vascular endothelial integrity (Monastral Blue staining) observed within 15 min of indomethacin administration, we investigated the possibility that leukotrienes (LTs) and platelet-activating factor (PAF) might be involved in the pathogenesis of indomethacin-induced ulceration. Changes in gastric LTB4 synthesis were not observed after indomethacin administration. Pretreatment with either an LTD4 antagonist or a PAF antagonist was without significant effect on the extent of gastric damage induced by indomethacin. These results suggest an important role for neutrophils in the pathogenesis of NSAID-induced gastric ulceration. Neutrophils may be important in the vascular injury that occurs early after administration of these compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169206     DOI: 10.1152/ajpgi.1990.259.3.G462

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  150 in total

1.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  Effect of diet on changes in small intestinal blood flow following intracolonic administration of indomethacin to rats.

Authors:  C Yamamoto; K Kawakubo; K Aoyagi; T Matsumoto; M Iida; S Ibayashi; T Kitazono; K Doi; K Kanamoto; M Fujishima
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

3.  Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin.

Authors:  Atsushi Nakajima; Toshiro Fukui; Yu Takahashi; Masanobu Kishimoto; Masao Yamashina; Shinji Nakayama; Yutaku Sakaguchi; Katsunori Yoshida; Kazushige Uchida; Akiyoshi Nishio; Junji Yodoi; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

4.  Eriobotrya japonica seed extract and deep sea water protect against indomethacin-induced gastric mucosal injury in rats.

Authors:  Junko Yokota; Taisuke Kitaoka; Kohei Jobu; Daisuke Takuma; Atsuhide Hamada; Masahide Onogawa; Saburo Yoshioka; Shojiro Kyotani; Mitsuhiko Miyamura
Journal:  J Nat Med       Date:  2010-07-17       Impact factor: 2.343

5.  Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury.

Authors:  Tatsushi Omatsu; Yuji Naito; Osamu Handa; Katsura Mizushima; Natsuko Hayashi; Ying Qin; Akihito Harusato; Ikuhiro Hirata; Etsuko Kishimoto; Hitomi Okada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Nobuaki Yagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2010-02-20       Impact factor: 7.527

6.  Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin.

Authors:  G Egger; A Burda; A Obernosterer; H Mitterhammer; G Kager; G Jürgens; H P Hofer; J S Fabjan; E Pilger
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

Review 7.  Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs.

Authors:  J E Keeble; P K Moore
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

8.  Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug.

Authors:  Mari Hagiwara; Keiko Kataoka; Hideki Arimochi; Tomomi Kuwahara; Haruyuki Nakayama; Yoshinari Ohnishi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

9.  Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin.

Authors:  A E Chávez-Piña; W McKnight; M Dicay; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 10.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.